Your browser doesn't support javascript.
COVID-19 Delta Variant: Perceptions, Worries, and Vaccine-Booster Acceptability among Healthcare Workers.
Alhasan, Khalid; Aljamaan, Fadi; Temsah, Mohamad-Hani; Alshahrani, Fatimah; Bassrawi, Rolan; Alhaboob, Ali; Assiri, Rasha; Alenezi, Shuliweeh; Alaraj, Ali; Alhomoudi, Reham I; Batais, Mohammed A; Al-Eyadhy, Lama; Halwani, Rabih; AbdulMajeed, Naif; Al-Jedai, Ahmed; Senjab, Abdulrahman; Memish, Ziad A; Al-Subaie, Sarah; Barry, Mazin; Al-Tawfiq, Jaffar A.
  • Alhasan K; Pediatric Department, College of Medicine, King Saud University, Riyadh 11451, Saudi Arabia.
  • Aljamaan F; Pediatric Department, King Saud University Medical City, Riyadh 11362, Saudi Arabia.
  • Temsah MH; Critical Care Department, College of Medicine, King Saud University, Riyadh 11451, Saudi Arabia.
  • Alshahrani F; Pediatric Department, College of Medicine, King Saud University, Riyadh 11451, Saudi Arabia.
  • Bassrawi R; Pediatric Department, King Saud University Medical City, Riyadh 11362, Saudi Arabia.
  • Alhaboob A; Prince Abdullah Ben Khaled Celiac Disease Research Chair, Department of Pediatrics, Faculty of Medicine, King Saud University, Riyadh 11451, Saudi Arabia.
  • Assiri R; Division of Infectious Diseases, Department of Internal Medicine, College of Medicine, King Saud University Medical City, King Saud University, Riyadh 11451, Saudi Arabia.
  • Alenezi S; Pediatric Department, King Saud University Medical City, Riyadh 11362, Saudi Arabia.
  • Alaraj A; Pediatric Department, College of Medicine, King Saud University, Riyadh 11451, Saudi Arabia.
  • Alhomoudi RI; Pediatric Department, King Saud University Medical City, Riyadh 11362, Saudi Arabia.
  • Batais MA; Department of Basic Medical Sciences, College of Medicine, Princess Nourah Bent Abdulrahman University, Riyadh 11451, Saudi Arabia.
  • Al-Eyadhy L; Department of Psychiatry, College of Medicine, King Saud University, Riyadh 11451, Saudi Arabia.
  • Halwani R; Department of Medicine, College of Medicine, Qassim University, Buraydah 51452, Saudi Arabia.
  • AbdulMajeed N; Department of Medicine, Doctor Sulaiman Al Habib Medical Group, Riyadh 11643, Saudi Arabia.
  • Al-Jedai A; Pediatric Department, King Saud University Medical City, Riyadh 11362, Saudi Arabia.
  • Senjab A; Department of Family and Community Medicine, College of Medicine, King Saud University, Riyadh 11451, Saudi Arabia.
  • Memish ZA; Pediatric Department, College of Medicine, King Saud University, Riyadh 11451, Saudi Arabia.
  • Al-Subaie S; Sharjah Institute of Medical Research, University of Sharjah, Sharjah 27272, United Arab Emirates.
  • Barry M; Department of Clinical Sciences, College of Medicine, University of Sharjah, Sharjah 27272, United Arab Emirates.
  • Al-Tawfiq JA; Pediatric Department, King Saud University Medical City, Riyadh 11362, Saudi Arabia.
Healthcare (Basel) ; 9(11)2021 Nov 17.
Article in English | MEDLINE | ID: covidwho-1523939
ABSTRACT

Background:

As the COVID-19 Delta variant has spread across the globe, healthcare workers' (HCWs) knowledge, worries, and vaccine booster acceptance should be assessed.

Methods:

Online questionnaires aimed at HCWs in Saudi Arabia were distributed between 9 and 12 August 2021, aiming to evaluate HCWs' perceptions and worries about the Delta variant as well as their feelings about receiving a booster-vaccine.

Results:

A total of 1279 HCWs participated, with 51.1% being physicians and 41.7% nurses. 92.5% were aware of the emergence of the Delta variant. Still, only 28.7% were found to have sufficient knowledge of the variant, and their level of worry about it was higher than their level of worry about the Alpha variant (2.32/5 versus 1.79/5). The main information sources cited by the participants were social media (50.5%), while 30.5% used scientific journals. Overall, 55.3% were willing to receive a vaccine booster, while one third would have preferred to receive a new mRNA vaccine specifically developed for the Delta variant. Factors associated with vaccine booster acceptance were receiving both vaccination doses (p = 0.008), believing that the Pfizer-BioNTech BNT162b2 vaccine is effective against variants (p < 0.001), and agreement that mixing/matching vaccines is effective against variants (p < 0.001).

Conclusions:

A high percentage of HCWs were aware of the Delta variant, but only a small fraction had decent quality of knowledge about it. The participants exhibited high worry levels and showed a modest acceptance of receiving a vaccine booster dose. These results should encourage public health officials to scale up educational efforts to disseminate reliable information about the different variants and provide recommendations about receiving a vaccine booster. Further research on methods to alleviate HCWs' worries about emerging variants is warranted.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Experimental Studies / Observational study Topics: Vaccines / Variants Language: English Year: 2021 Document Type: Article Affiliation country: Healthcare9111566

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Experimental Studies / Observational study Topics: Vaccines / Variants Language: English Year: 2021 Document Type: Article Affiliation country: Healthcare9111566